According to Mediclin's latest financial reports the company's current EPS (TTM) is โน13.23. a decrease over its 2022 EPS that were of โน18.34.
Year | EPS | Change |
---|---|---|
2023 | -โน21.73 | -218.52% |
2022 | โน18.34 | 531.45% |
2021 | โน2.90 | -114.54% |
2020 | -โน19.98 | -204.31% |
2019 | โน19.15 | 22.4% |
2018 | โน15.65 | 90.69% |
2017 | โน8.21 | -73.93% |
2016 | โน31.47 | -3.8% |
2015 | โน32.71 | 74.81% |
2014 | โน18.71 | -364.2% |
2013 | -โน7.08 | 108.81% |
2012 | -โน3.39 | -150.93% |
2011 | โน6.66 | -72.1% |
2010 | โน23.88 | -11.38% |
2009 | โน26.94 | 2.48% |
2008 | โน26.29 | 17.02% |
2007 | โน22.47 | -33.61% |
2006 | โน33.84 | 28.52% |
2005 | โน26.33 | -142.84% |
2004 | -โน61.46 | 7.74% |
2003 | -โน57.04 |